Both in Pharmaceuticals
UroGen Pharma vs Tyra Biosciences
Over the past year URGN returned +45.1% and TYRA returned +43.5%; their daily moves had a correlation of 0.03.
URGN +45.1% TYRA +43.5%Growth of $1, one year, split-adjusted
| Metric | URGN | TYRA |
|---|---|---|
| Price | $28.74 | $21.53 |
| Market cap | $1.40B | $1.48B |
| Today | −16.45% | +0.73% |
| 1 month | −30.6% | +6.3% |
| 6 months | +9.5% | −36.3% |
| Year to date | +22.7% | −18.1% |
| 1 year | +39.4% | +39.5% |
| Revenue growth (YoY) | +199.2% | — |
| Gross margin | 90.9% | — |
| Net margin | −19.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.4× | — |
| Net cash | -$85.1M | $353.9M |
| Dividend yield | — | — |
| Volatility (60d) | 54.9% | 74.2% |
| Short % of float | 12.3% | 26.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).